Clinical trials
Phase 2 Overweight trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
235 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 5 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 15 |
| 2009 | 7 |
| 2010 | 2 |
| 2011 | 6 |
| 2012 | 6 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 8 |
| 2022 | 7 |
| 2023 | 20 |
| 2024 | 29 |
| 2025 | 41 |
| 2026 | 39 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 135 |
| Recruiting | 32 |
| Active, not recruiting | 20 |
| Not yet recruiting | 19 |
| Unknown status | 13 |
| Terminated | 9 |
| Withdrawn | 4 |
| Enrolling by invitation | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 16 |
| AstraZeneca | 9 |
| Shanghai Minwei Biotechnology Co., Ltd | 5 |
| The Miriam Hospital | 5 |
| Carmot Therapeutics, Inc. | 4 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 4 |
| Novo Nordisk A/S | 4 |
| Pfizer | 4 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 3 |
| Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 235 |
| Obesity | 216 |
| Weight Loss | 31 |
| Diabetes Mellitus, Type 2 | 27 |
| Body Weight | 13 |
| Insulin Resistance | 13 |
| Diabetes Mellitus | 9 |
| Metabolic Syndrome | 8 |
| Prediabetic State | 6 |
| Hypertension | 5 |
Trials
Showing 26 to 50 of 235. Each trial links to its page on Pharma Observatory.
135 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.